Search
Descriptor English: Octreotide
Descriptor Spanish: Octreótido
Descriptor octreótido
Entry term(s) acetato de octreótido
Scope note: Potente análogo octapéptido de la SOMATOSTATINA, de acción prolongada, que inhibe la secreción de la HORMONA DEL CRECIMIENTO y se utiliza en el tratamiento de tumores secretores de hormonas, DIABETES MELLITUS, HIPOTENSIÓN ORTOSTÁTICA, HIPERINSULINISMO, hipergastrinemia y fístulas del intestino delgado.
Descriptor Portuguese: Octreotida
Descriptor French: Octréotide
Entry term(s): Compound 201 995
Compound 201-995
Compound 201995
Octreotide Acetate
Octreotide Acetate Salt
SAN 201 995
SAN 201-995
SAN 201995
SM 201 995
SM 201-995
SM 201995
SMS 201 995
SMS 201-995
SMS 201995
Sandostatin
Sandostatine
Sandoz 201 995
Sandoz 201-995
Sandoz 201995
Tree number(s): D04.345.566.650
D12.644.641.650
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D015282
Scope note: A potent, long-acting synthetic SOMATOSTATIN octapeptide analog that inhibits secretion of GROWTH HORMONE and is used to treat hormone-secreting tumors; DIABETES MELLITUS; HYPOTENSION, ORTHOSTATIC; HYPERINSULINISM; hypergastrinemia; and small bowel fistula.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Gastrointestinal Agents
Antineoplastic Agents, Hormonal
Registry Number: RWM8CCW8GP
CAS Type 1 Name: L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-(2-hydroxy-1-(hydroxymethyl)propyl)-, cyclic (2-7)-disulfide, (R-(R*,R*))-
Previous Indexing: Antineoplastic Agents (1982-1988)
Somatostatin/analogs & derivatives (1982-1988)
Public MeSH Note: 89
History Note: 89
DeCS ID: 23785
Unique ID: D015282
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1989/01/01
Date of Entry: 1988/05/23
Revision Date: 2013/07/08
Octreotide - Preferred
Concept UI M0023526
Scope note A potent, long-acting synthetic SOMATOSTATIN octapeptide analog that inhibits secretion of GROWTH HORMONE and is used to treat hormone-secreting tumors; DIABETES MELLITUS; HYPOTENSION, ORTHOSTATIC; HYPERINSULINISM; hypergastrinemia; and small bowel fistula.
Preferred term Octreotide
SMS 201-995 - Narrower
Concept UI M0333645
Preferred term SMS 201-995
Entry term(s) Compound 201 995
Compound 201-995
Compound 201995
SAN 201 995
SAN 201-995
SAN 201995
SM 201 995
SM 201-995
SM 201995
SMS 201 995
SMS 201995
Sandoz 201 995
Sandoz 201-995
Sandoz 201995
Octreotide Acetate - Narrower
Concept UI M0329524
Preferred term Octreotide Acetate
Entry term(s) Octreotide Acetate Salt
Sandostatine - Narrower
Concept UI M0023528
Preferred term Sandostatine
Entry term(s) Sandostatin



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey